| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | — | -21.0% |
| Cost of Revenue | $2.4M | — | +7.1% |
| Gross Profit | -$394K | — | -236.3% |
| R&D Expense | $6K | — | -94.1% |
| SG&A Expense | $3.7M | — | +15.2% |
| Operating Income | -$4.1M | — | -39.7% |
| Pre-tax Income | -$6.8M | — | -35.2% |
| Net Income | -$6.9M | — | -35.5% |
| EPS (Basic) | -$71.28 | — | -204.0% |
| EPS (Diluted) | -$71.28 | — | -204.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $476K | +222.4% | +39.7% |
| Accounts Receivable | $693K | -27.0% | -45.8% |
| Inventory | $2.4M | -13.4% | -43.2% |
| Current Assets | $5.5M | -1.9% | -10.5% |
| Total Assets | $30.7M | -3.5% | +216.6% |
| Current Liabilities | $22.2M | -14.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.0M | — | -87.7% |
| Capital Expenditures | $2K | — | +0.0% |
| Investing Cash Flow | -$2K | — | +0.0% |
| Financing Cash Flow | $604K | — | +0.3% |
| Free Cash Flow | -$1.0M | — | -87.3% |
| +42.2% |
| Total Liabilities | $23.5M | -14.2% | +32.9% |
| Stockholders' Equity | $7.2M | +64.0% | +189.7% |